COMMENTARY ON THE LAW
[Lipoprotein (a) in physiological states and kidney diseases]
E Franek 1 , F Kokot
1. Klinika Nefrologii, Endokrynologii i Chorób Metabolicznych Slaskiej AkademiiMedycznej w Katowicach.
Published:
GICID: 01.3001.0000.3153
Available language versions: en pl
Issue: Postepy Hig Med Dosw 1997; 51 (6)
Abstract
The present paper is a concise summary of contemporary knowledge of lipoprotein(a). Increased lipoprotein(a) concentration is an independent risk factor for atherogenesis. The treatment of choice of increased lipoprotein(a) concentration is causal–for example treatment of the nephrotic syndrome or renal transplantation. If this is not amenable, careful monitoring and elimination of additional risk factors of atherogenesis are mandatory.